 |
|
|
| Arbeitskreis Omega-3 e. V. |
|
|
|
| In diesem Abschnitt finden Sie einige ausgewählte Publikationen zum Thema Omega-3-Fettsäuren. Wir werden die Liste stetig ergänzen. |
|
Literatur zu Omega-3-Fettsäuren und Herz-Kreislauf-Erkrankungen
American Heart Association AHA (2006): Scientific Statement; Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee. Circulation 114: 82-96
Albert, C. M., Campos, H. et al. (2002): Blood level of long-chain n-3 fatty acids and risk of sudden cardiac death. N. Engl. J. Med.: 346 (15) : 1113-1118
Bahri, D. et al. (2002): Bedeutung und empfehlenswerte Höhe der Zufuhr langkettiger Omega-3-Fettsäuren. Ein Konsensus-Statement des Arbeitskreises Omega-3. Ernährungs-Umschau 49: 94-98
Biscione, F. et al. (2007): Cardiovascular effects of omega-3 free fatty acids. Curr. Vasc. Pharmacol. 5: 163-172
Brown A. A., Hu F. B. (2001): Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr Apr 73 (4) : 673-686
Bucher H. C., Hengstler P., Schindler C., Meier G. (2002): N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trial. Am J Med 112: 298-304
Carrero J. J. et al. (2004): Cardiovascular effects of milk enriched with omega-3 polyunsaturated fatty acids, oleic acid, folic acid, and vitamins E and B6 in volunteers with mild hyperlipidemia. Nutrition Jun; 20 (6) : 521-527
Davidson, M. H. (2006): Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol 98 (4A) : 27i-33i
Deckelbaum R. J. et al. (2006): n-3 Fatty acids and gene expression. Am J Clin Nutr 83 (suppl) : 1520-1525
Goodfellow J. et al. (2000): Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelialfunction in subjects with hypercholesterolemia: J Am Coll Cardiol Feb; 35 (2) : 265-270
Harris, W. S. et al. (2007): Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 2007 193: 1-10
He K., Song Y., Daviglus M.L., Liu K., Van Horn L., Dyer A.R. et al. (2004): Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation 109: 2705-2711
ISSFAL (2004): Recommendations for intake of polyunsaturated fatty acids in healthy adults. siehe auch: - http://www.issfal.org.uk/lipid-matters/issfal-policy-statements/statement-3-pufa-in-adults-9.html
Jacobson, T. A. (2007): Beyond Lipids: the role of mega-3 fatty acids from fish oil in the prevention of coronary heart disease. Curr Atheroscler Rep 9: 145-153
Hu, F. B. et al. (2003): Fish and long-chain n-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation 107: 1852-1857
Kawamori R. (2007): Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes. ; Atherosclerosis Mar; 191 (1) :162-167
Kelley, D. S. et al. (2007): Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hyertriglyceridemic men. Am J Clin Nutr 86: 324-333
Koch, S. (2007): Omega-3-Fettsäuren aktuell. Konsequenzen und Perspektiven für die Ernährungsberatung. Ernährungs-Umschau (8): 482-485
Kromhout, D. et al. (1985): The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 312: 1205-1209
Leaf, A. et al. (2008): Fish oil fatty acids as cardiovascular drugs. Curr Vasc Pharmacol 6: 1-12
Lichtenstein A. H., Appel L. J., Brands M. et al. (2006): Diet and lifestyle recommendations revision 2006. A scientific statement from the American Heart Association Nutrition Committee. Circulation 114: 82-96
Marchioli, R. et al. (2007): Efficacy of n-3 polyunsaturated fatty acids: insights from the GISSI-Prevenzione trial. J Cardiovasc Med 8 (Suppl 1): 34-37
Marckmann, P. et al. (1999): Fish consumption and coronary heart disease mortality. A systematic review of prospective cohort studies. Eur J Clin Nutr 8: 585-590
Mckenney J. M., Sica, D. (2007): Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia. Pharmacotherapy 27: 715-728
Mori T. A. et al. (2000): Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation Sep 12; 102 (11) :1264-1269
Mori T. A., Woodman R.J. (2006): The independent 855 effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Curr Opin Clin Nutr Metab Care 9 (2) : 95-104
Mozaffarian, D. et al. (2005): Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 111 (2) : 157-164
Richter; V. et al. (2007): Cardiovascular risk factor profile on a population basis: Results from the Lipid Study Leipzig. Exp Clin Cardiol 12: 51-53
Richter, V.; Rassoul, F.; Hamm, M. (2008): Omega-3-Fettsäuren und kardiovaskuläres Risiko: Konsens trotz weiteren Forschungsbedarfs. Perfusion 21: 50-55
Singer, P. (2002): Fluvastatin und Fischöl wirken stärker auf kardiovaskuläre Risikofaktoren als Fluvastatin allein. Med Welt 53: 298-302
Valentine R. C., Valentine D. L. (2004): Omega-3 fatty acids in cellular membranes: a unified concept. Prog Lipid Res 43: 383-402
von Schacky, C. (2007): Omega-3 fatty acids and cardiovascular disease. Curr Opin Clin Nutr Metab Care 10: 129-135
von Schacky, C. (2007): Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res 73: 310-315
von Schacky C. (2006): A review of omega-3 ethyl esters for the cardiovascular prevention and treatment of increased blood triglyceride levels. Vascular Health and Risk Management 2 (3) : 251-262
Visioli F. et al. (2000): Very low intakes of n-3 fatty acids incorporated into bovine milk reduce plasma triacylglycerol and increase HDL-cholesterol concentrations in healthy subjects. Pharmacol Res 41: 571-576
Wang, C. et al. (2006): n-3 fatty acids from fish or fish oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary - and secondary - prevention studies: a systematic review. Am. J Clin Nutr 84: 5-17
Whelton S. P., He J., Whelton P. K., Muntner P. (2004): Meta-analysis of observational studies on fish intake and coronary heart disease. Am J Cardiol 93: 1119-1123
Yamada, T. et al. (2000): Atherosclerosis and n-3 fatty acids in the population of a fishing village and a farming village in Japan. Atherosclerosis 153: 469-481
Yuan, J. M. et al. (2001): Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghei, China. Am J Epidemiol 154 (9) : 809-816
Literatur zu Omega-3-Fettsäuren und Gehirnfunktion
Anderson, G. J. et al (1990): Docosahexaenoic acid is the preferred dietary n-3 fatty acid for the development of the brain and retina. Pediatric Res 27 : 89-97
Arbeitskreis Omega-3 (2002): Bedeutung und empfehlenswerte Hähe der Zufuhr langkettiger Omega-3-Fettsäuren - Ein Konsensus-Statement des Arbeitskreis Omega-3. Ernährungs-Umschau 49, 94-98
Beydoun M. A., Kaufman J. S., Satia J. A., Rosamond W., Folsom A. R. (2007): Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. Am J Clin Nutr 85:1103-1111
Bourre J. M. (2006): Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2: macronutrients. J Nutr Health Aging Sep-Oct 10(5):386-399. Review
Brenna J. T. (2005): Meeting Report: European consensus conference on recommendations for long chain polyunsaturated consumption for pregnant and lactating women (PERILIP). ISSFAL Newsletter 12: 4-6
Colombo, J. et al (2004): Maternal DHA and the development of attention in infancy and toddlerhood. Child Development 75: 1254-1267
Conklin S. M. et al. (2007): Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neurosci Lett. Jun 29; 421 (3) : 209-212. Epub (2007) Jun 2.
Conklin S. M. et al. (2007): Serum omega-3 fatty acids are associated with variation in mood, personality and behavior in hypercholesterolemic community volunteers. Psychiatry Res. Jul 30; 152 (1) : 1-10. Epub (2007) Mar 23.
Connor W. E., Connor S. L. (2007): The importance of fish and docosahexaenoic acid in Alzheimer disease. Am J Clin Nutr. 85 (4) : 929-930
Crowe F. L. et al. (2007): Serum phospholipid n 3 long-chain polyunsaturated fatty acids and physical and mental health in a population-based survey of New Zealand adolescents and adults. Am J Clin Nutr. 86 (5) : 1278-1285
Dangour A. D. et al. (2006): A randomised controlled trial investigating the effect of n-3 long-chain polyunsaturated fatty acid supplementation on cognitive and retinal function in cognitively healthy older people: the Older People And n-3 Long-chain polyunsaturated fatty acids (OPAL) study protocol [ISRCTN72331636]. Nutr J. 31; 5-20
Dullemeijer C. et al. (2007): n 3 Fatty acid proportions in plasma and cognitive performance in older adults. Am J Clin Nutr. 86 (5) :1479-1485
EFSA (European Food Safety Authority) (2005b): Opinion of the Scientific Panel on Dietetic Products, Nutrition and Allergies on a request from the Commission related to nutrition claims concerning omega-3 fatty acids, monounsaturated fat, polyunsaturated fat and unsaturated fat. The EFSA Journal 253: 1-29 siehe auch: - http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1178620767233.htm
EFSA (European Food Safety Authority) (2008): Opinion on the setting of nutrient profiles for foods bearing nutrition and health claims pursuant to Article 4 of the Regulation (EC) No 1924/2006
Fernando G. P. (2008): Science and society: Brain foods: the effects of nutrients on brain function. Nature Reviews Neuroscience 9, 568-578
Fontani G., Corradeschi F., Felici A., Alfatti F., Migliorini S. et al. (2005): Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J Clin Invest 35 (11) : 691-699
Haag, M. (2003): Essential fatty acids and the brain. Can. J. Psychiatr. 48 (3) : 195-203
Hartmann T. et al. (2007): Alzheimer's disease: the lipid connection. J Neurochem. Nov; 103 Suppl 1: 159-170. Review.
Heude B., Ducimetière P., Berr C. (2003): Cognitive decline and fatty acid composition of erythrocyte membranes - the EVA study. Am J Clin Nutr 77: 803-808
Hibbeln R. et al. (2006): Omega-3 fatty acid deficiencies in neurodevelopment, aggression and autonomic dysregulation: Opportunities for intervention. International Review of Psychiatry Vol. 18 (2) : 107-118
Hirayama S., Hamazaki T., Terasawa K. (2004): Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder- a placebo- controlled double-blind study. European Journal of Clinical Nutrition 58: 467-473
Innis S. M. (2007): Dietary (n-3) fatty acids and brain development. J Nutr. Apr; 137 (4) : 855-859. Review
Hirayama S., Hamazaki T., Terasawa K. (2004): Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder- a placebo- controlled double-blind study. European Journal of Clinical Nutrition 58: 467-473
Innis S. M. (2007): Dietary (n-3) fatty acids and brain development. J Nutr. Apr; 137 (4) : 855-859. Review
ISSFAL (2004): Recommendations for intake of polyunsaturated fatty acids in healthy adults. siehe auch: - http://www.issfal.org.uk/lipid-matters/issfal-policy-statements/statement-3-pufa-in-adults-9.html
Johnson E. J., Schaefer E. J. (2006): Potential role of dietary n-3 fatty acids in the prevention of dementia and macular degeneration. Am J Clin Nutr. Jun; 83 (6 Suppl):1494-1498. Review. Erratum in: Am J Clin Nutr. 2006 Dec; 84(6):1555
Kalmijn S. et al. (2004): Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology. Jan 27; 62 (2) : 275-280
Kidd P. M. (2007): Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev. Sep;12 (3): 207-227
Kotani S. et al. (2006): Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci Res. Oct; 56 (2) : 159-164. Epub (2006) Aug 14
Kyle D. J. et al. (1999): Low serum docosahexaenoic acid is a significant risk factor for Alzheimers dementia. Lipids 34: 245
Larque, E. et al (2002): Perinatal supply and metabolism of long-chain polyunsaturated fatty acids. Importance for the early development of the nervous system. Ann NY Acad Sci 967: 299-310
Lauretani F. et al. (2007): Omega-6 and omega-3 fatty acids predict accelerated decline of peripheral nerve function in older persons. Eur J Neurol. Jul; 14 (7) : 801-808
Levi F. et al. (2006): Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol. Oct; 63 (10) : 1402-1408
Max Rubner-Institut, Institut für Qualität und Sicherheit bei Milch und Fisch (Institutsteil Fisch) (2008): Fisch. siehe auch: - http://www.mri.bund.de/nn_784936/DE/forschung/hamburg/Downloads/ern__kinder%2CtemplateId=raw%2Cproperty=publicationFile.pdf/ern_kinder.pdf
McCann J. C., Ames B. N. (2005): Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr. Aug; 82 (2) : 281-95. Review
McNamara R. K., Carlson S. E. (2006): Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot Essent Fatty Acids 75: 329-349
Morris M. C. et al. (2005): Fish consumption and cognitive decline with age in a large community study.Arch Neurol Dec 62 (12) : 1849-1853. Epub (2005) Oct 10
Mukherjee P. K. et al. (2007): Docosanoids are multifunctional regulators of neural cell integrity and fate: Significance in aging and disease. Prostagland. Leukot. Essent. Fatty Acids 77: 233-238
Neuringer, M. (2000): Infant vision and retinal function of dietary long-chain poly unsaturated fatty acids: methods, results, and implications. Am J. Clin. Nutr. Suppl.: 256-267
Oksman M., Hogyes I. E., Amtul Z., et al. (2006): Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PSI transgenic mice. Neurobiol Dis 23: 563-572
Reis L. C. et al. (2006): Cultural symbolism of fish and the psychotropic properties of omega-3 fatty acids. In: Prostaglandins Leukot Essent Fatty Acids, Oct-Nov 75 (4-5) : 227-236
Schaefer E. J. et al. (2006): Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol. Nov; 63 (11) : 1545-1550
Scientific Advisory Committee on Nutrition (UK) (2004): Advice on fish consumption, paragraph 5.18. ISBN 0 11 243083. The Stationary Office.
(accessed 2.2.09 ) siehe auch: - http://www.sacn.gov.uk/pdfs/fics_sacn_advice_fish.pdf
Simopoulos, A. P. (1991): Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr. 54: 438-463
Simopoulos A. P., Leaf A., Salem N. Jr. (1999): Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Ann Nutr Metab 43:127-130
Trautwein, A. (1999): Fette und Fettbegleitstoffe. Omega-3-Fettsäuren. In: Erbersdobler, H. F., Meyer, A. H. (Hrsg.): Praxishandbuch Functional Food, Behrs Verlag Hamburg
Uauy, R. et al (2001): Essential fatty acids in visual and brain development. Lipids 36: 885-895
Uauy R., Dangour A. D. (2006): Nutrition in brain development and aging: role of essential fatty acids. Nutr Rev 64 (5 Pt 2): 24-33; discussion S 72-91
Wainwright P. (2000): Nutrition and behaviour: The role of n-3 fatty acids in cognitive function. Br J Nutr 83: 337-339
Literatur zu Omega-3-Fettsäuren und Augenfunktion
Whalley L. J., Fox H. C., Wahle K. W., Starr J. M., Deary I. J. (2004): Cognitive aging, childhood intelligence, and the use of food supplements: possible involvement of n-3 fatty acids. Am J Clin Nutr 80: 1650-1657
Anderson, G.J. et al (1990). Docosahexaenoic acid is the preferred dietary n-3 fatty acid for the development of the brain and retina. Pediatric Res 27: 89-97
Cardiovascular Review Group, Committee on Medical Aspects of Food Policy. Nutritional aspects of cardiovascular disease (1994). Report on Health and Social Subjects. London, United Kingdom: Department of Health
Cho E et al. (2001): Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr Feb 73 (2) :209-218
Chong E. W. et al. (2006): The Associations of Dietary Lutein, Zeaxanthin and Fats with Age-Related Macular Degeneration: The Melbourne Collaborative Cohort Study. Invest Ophthalmol Vis Sci
Chong E. W. et al. (2008): Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol Jun 126 (6) : 826-833
Chong E. W. et al. (2008): Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol Jun 126 (6) : 826-833
Chua B. et al. (2006): Dietary fatty acids and the 5-year incidence of age-related maculopathy. Arch Ophthalmol Jul 124 (7) : 981-986
Dangour A. D. et al. (2006): A randomised controlled trial investigating the effect of n-3 long-chain polyunsaturated fatty acid supplementation on cognitive and retinal function in cognitively healthy older people: the Older People And n-3 Long-chain polyunsaturated fatty acids (OPAL) study protocol [ISRCTN72331636]. Nutr J Aug 31; 5: 20
20 Fliesler S. J., Anderson, R. E. (1983): Chemistry and metabolism of lipids in the vertebrate retina. Prog Lipid Res 22: 79-131
Hodge W. G., Barnes D., Schachter H. M. (2007): Evidence for the effect of omega-3 fatty acids on progression of age-related macular degeneration: a systematic review. Retina Feb 27 (2) : 216-221
Hodge W. G., Barnes D., Schachter H. M. (2006): The evidence for efficacy of omega-3 fatty acids in preventing or slowing the progression of retinitis pigmentosa: a systematic review. Can J Ophthalmol Aug 41 (4) : 481-490
Hoffman D. R. et al. (2004): A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa. Am J Ophthalmol Apr 137 (4) : 704-718
Jeffrey, B. G. et al. (2001): The role of docosahexaenoic acid in retinal function. Lipids 36: 859-871
Johnson E. J., Schaefer E. J. (2006): Potential role of dietary n-3 fatty acids in the prevention of dementia and macular degeneration. Am J Clin Nutr Jun 83 (6 Suppl.): 1494-1498 Review. Erratum in: Am J Clin Nutr 2006 Dec 84 (6) :1555
Judge, M. P., Harel, O., Lammi-Keefe, C. J. (2007): A docosahexaenoic acid-functional food during pregnancy benefits infant visual acuity at four but not six months of age. Lipids 42 (2) : 117-122
Miljanovic B. et al. (2005): Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr Oct 82 (4) : 887-893
Neuringer, M. (2000): Infant vision and retinal function of dietary long-chain poly unsaturated fatty acids: methods, results, and implications. Am J Clin Nutr Suppl.: 256-267
"Proretina e. V": siehe auch: - http://www.pro-retina.de/deu/forschung/wissenschaftliche_beratungsgremien/empfehlungen/amd_und_ernaehrung.html
Robman L. et al. (2007): Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration. Can J Ophthalmol Oct 42 (5) :720-726
Rojas, C. V. et al. (2003): Gene expression analysis in human fetal retinal explants treated with docosahexaenoic acid. Invest Ophthalmol Vis Sci 44: 3170-3177
SanGiovanni J. P., Chew E. Y. (2005): The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res Jan 24 (1) : 87-138. Review
SanGiovanni J. P., Chew E. Y., Clemons T. E., Davis M. D., Ferris F. L. (2007): 3rdAge-Related Eye Disease Study Research Group: The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol May 125 (5) : 671-679
Scorolli L. et al. (2002): Photodynamic therapy for age related macular degeneration with and without antioxidants. Can J Ophthalmol Dec 37 (7) : 399-404. French.
Seddon J. M., George S., Rosner B. (2006): Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol Jul 124 (7) : 995-1001
Simopoulos, A. (1991): Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 54: 438-463
Uauy, R. et al (2001): Essential fatty acids in visual and brain development. Lipids 36: 885-895
|
